|
37984078 |
0 |
Wang TF, Delluc A, Cervi A, et al.
A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer.
Thromb Res. 2023 Nov 16;233:10-13. doi: 10.1016/j.thromres.2023.11.012.
|
|
36100263 |
0 |
Auer RC, Ott M, Karanicolas P, et al.
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.
BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
|
|
34807722 |
0 |
Le Gal G, Kovacs MJ, Bertoletti L, et al.
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
|
|
34108229 |
0 |
Kovacs MJ, Wells PS, Anderson DR, et al.
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
|
|
31066471 |
0 |
McCurdy JD, Israel A, Hasan M, et al.
A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 2019 Jun;49(12):1493-1501. doi: 10.1111/apt.15286. Epub 2019 May 8.
|
|
28314711 |
0 |
Rodger MA, Le Gal G, Anderson DR, et al.
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.
BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.
|
|
26990353 |
0 |
Clark EG, Rodger MA, Ramsay TO, et al.
Effectiveness of a computerized decision support system for anticoagulation management in hemodialysis patients: A before-after study.
Hemodial Int. 2016 Oct;20(4):530-536. doi: 10.1111/hdi.12411. Epub 2016 Mar 17.
|
, McMaster University